Quick Summary:
Stepping into the medical technology landscape, the global biopsy devices market holds significant promise for business expansion and strategic investment. The increasing prevalence of chronic diseases, including cancer, and rising consumer awareness about diagnostic and screening procedures are key drivers amplifying growth in this sector. Offering invaluable insights, this comprehensive market report provides an unrivalled depth of analysis and detailed forecasts.
The report addresses an expansive range of applications across multiple healthcare institutions, making it an indispensable tool for players both established and new in the biopsy devices industry. With its detailed coverage of the market segmentation based on procedure types, products, guidance techniques, applications and end-users on a global, regional and country level, this market research equips you with the strategic intelligence to identify opportunities for investments and business growth. Make informed decisions powered by expert research, market insights and industry trends detailed in this report.
The global biopsy devices market size reached US$ 2.5 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.
Biopsy devices refer to various equipment that are used for surgical extraction of tissues from an organ. They are utilized by surgeons, radiologists, cardiologists and other medical practitioners to diagnose the presence or extent of diseases that are cancerous or inflammatory in nature. Equipment such as aspiration needles, forceps and localization wires are some of the commonly used biopsy devices. These devices are used in MRI-guided, needle-based, core and vacuum-assisted biopsies of body parts, including the liver, lungs, kidneys and breasts. They find extensive applications across numerous healthcare institutions, such as medical clinics, diagnostic centres and hospitals.
The rising instances of chronic medical ailments, especially breast cancer, is one of the key factors driving the growth of the market. Furthermore, rising consumer awareness regarding the availability of diagnostic and screening procedures for chronic diseases is boosting the demand for integrated technologies such as stereotactic-guided biopsies. There is also a growing preference for minimally invasive (MI) biopsy procedures among patients across the globe. For instance, the MI breast biopsy technique (MIBT) eliminates the need for surgery for cancer diagnosis while preserving healthy tissues from damage caused by radiation. Additionally, various technological advancements, including the development of vacuum-assisted guns and smart biopsy systems that aid in distinguishing healthy cells from tumorous ones, are also favoring the market growth. Other factors, including the rapidly growing geriatric population, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the coming years.
Biopsy devices refer to various equipment that are used for surgical extraction of tissues from an organ. They are utilized by surgeons, radiologists, cardiologists and other medical practitioners to diagnose the presence or extent of diseases that are cancerous or inflammatory in nature. Equipment such as aspiration needles, forceps and localization wires are some of the commonly used biopsy devices. These devices are used in MRI-guided, needle-based, core and vacuum-assisted biopsies of body parts, including the liver, lungs, kidneys and breasts. They find extensive applications across numerous healthcare institutions, such as medical clinics, diagnostic centres and hospitals.
The rising instances of chronic medical ailments, especially breast cancer, is one of the key factors driving the growth of the market. Furthermore, rising consumer awareness regarding the availability of diagnostic and screening procedures for chronic diseases is boosting the demand for integrated technologies such as stereotactic-guided biopsies. There is also a growing preference for minimally invasive (MI) biopsy procedures among patients across the globe. For instance, the MI breast biopsy technique (MIBT) eliminates the need for surgery for cancer diagnosis while preserving healthy tissues from damage caused by radiation. Additionally, various technological advancements, including the development of vacuum-assisted guns and smart biopsy systems that aid in distinguishing healthy cells from tumorous ones, are also favoring the market growth. Other factors, including the rapidly growing geriatric population, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the coming years.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global biopsy devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on procedure type, product, application, guidance technique and end-user.Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound Guided Biopsy
- Stereotactic Guided Biopsy
- MRI Guided Biopsy
- Others
Breakup by End-User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Breakup by Region:
North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Argon Medical Devices Inc., B. Braun Melsungen, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Group Incorporated, Danaher Corporation, Hologic Inc., Medtronic Inc., etc.Key Questions Answered in This Report:
- How has the global biopsy devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global biopsy devices market?
- What is the breakup of the market based on the procedure type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the guidance technique?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biopsy devices market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Biopsy Devices Market
What is the estimated value of the Global Biopsy Devices Market?
What is the growth rate of the Global Biopsy Devices Market?
What is the forecasted size of the Global Biopsy Devices Market?
Who are the key companies in the Global Biopsy Devices Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 142 |
| Published | May 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 2.5 Billion |
| Forecasted Market Value ( USD | $ 3.7 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Indicators
2 Scope and Methodology
4 Introduction
5 Global Biopsy Devices Market
6 Market Breakup by Procedure Type
7 Market Breakup by Product
8 Market Breakup by Application
9 Market Breakup by Guidance Technique
10 Market Breakup by End-User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Argon Medical Devices Inc.
- B. Braun Melsungen
- Becton
- Dickinson and Company
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Group Incorporated
- Danaher Corporation
- Hologic Inc.
- Medtronic Inc.
Methodology
LOADING...
